CN104173481B - 一种抗前列腺炎症的中药组合物及其制备方法和应用 - Google Patents
一种抗前列腺炎症的中药组合物及其制备方法和应用 Download PDFInfo
- Publication number
- CN104173481B CN104173481B CN201410472993.2A CN201410472993A CN104173481B CN 104173481 B CN104173481 B CN 104173481B CN 201410472993 A CN201410472993 A CN 201410472993A CN 104173481 B CN104173481 B CN 104173481B
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine composition
- resistance prostatitis
- prostatitis disease
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 50
- 201000007094 prostatitis Diseases 0.000 title claims abstract description 45
- 239000000203 mixture Substances 0.000 title claims abstract description 39
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 241000005787 Cistanche Species 0.000 claims abstract description 16
- 241000628997 Flos Species 0.000 claims abstract description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 239000011347 resin Substances 0.000 claims description 14
- 229920005989 resin Polymers 0.000 claims description 14
- 230000000274 adsorptive effect Effects 0.000 claims description 10
- 239000003480 eluent Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 9
- 229940079593 drug Drugs 0.000 claims description 6
- 238000010828 elution Methods 0.000 claims description 6
- 239000006210 lotion Substances 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 5
- 230000006837 decompression Effects 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- 239000003463 adsorbent Substances 0.000 claims description 3
- 238000010521 absorption reaction Methods 0.000 claims description 2
- 238000009835 boiling Methods 0.000 claims description 2
- 239000006071 cream Substances 0.000 claims description 2
- 238000004821 distillation Methods 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 238000011282 treatment Methods 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 230000002349 favourable effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 20
- 235000019441 ethanol Nutrition 0.000 description 12
- 230000003110 anti-inflammatory effect Effects 0.000 description 6
- 230000033228 biological regulation Effects 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 235000010418 carrageenan Nutrition 0.000 description 5
- 229920001525 carrageenan Polymers 0.000 description 5
- 208000013507 chronic prostatitis Diseases 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 239000004375 Dextrin Substances 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 3
- 241000736199 Paeonia Species 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical group CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 3
- 201000003265 lymphadenitis Diseases 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 238000004064 recycling Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 241000336316 Cistanche tubulosa Species 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- 241001278898 Glycyrrhiza inflata Species 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 2
- 229960002986 dinoprostone Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 206010069918 Bacterial prostatitis Diseases 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 241000208828 Caprifoliaceae Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 229930194248 Licoflavone Natural products 0.000 description 1
- MEHHCBRCXIDGKZ-UHFFFAOYSA-N Licoflavone C Natural products CC(C)=CCC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 MEHHCBRCXIDGKZ-UHFFFAOYSA-N 0.000 description 1
- 244000167230 Lonicera japonica Species 0.000 description 1
- 235000017617 Lonicera japonica Nutrition 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 241000308150 Orobanchaceae Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 208000000450 Pelvic Pain Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 206010036968 Prostatic pain Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002804 anti-anaphylactic effect Effects 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000009863 impact test Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410472993.2A CN104173481B (zh) | 2014-09-17 | 2014-09-17 | 一种抗前列腺炎症的中药组合物及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410472993.2A CN104173481B (zh) | 2014-09-17 | 2014-09-17 | 一种抗前列腺炎症的中药组合物及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104173481A CN104173481A (zh) | 2014-12-03 |
CN104173481B true CN104173481B (zh) | 2016-09-21 |
Family
ID=51955004
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410472993.2A Active CN104173481B (zh) | 2014-09-17 | 2014-09-17 | 一种抗前列腺炎症的中药组合物及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104173481B (zh) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101264210A (zh) * | 2008-05-08 | 2008-09-17 | 北京天科仁祥医药科技有限公司 | 一种治疗前列腺炎的中草药 |
CN102342980A (zh) * | 2010-07-28 | 2012-02-08 | 陈登 | 一种治疗男性前列腺炎的中药及其治疗方法 |
CN103446227A (zh) * | 2012-05-31 | 2013-12-18 | 赵骁栋 | 一种治疗慢性前列腺炎的中药 |
KR101432245B1 (ko) * | 2012-06-11 | 2014-09-18 | 가톨릭대학교 산학협력단 | 검정콩으로부터 추출한 안토시아닌을 포함하는 세균성 전립선염의 예방 및 치료용 조성물 |
KR101404150B1 (ko) * | 2012-09-26 | 2014-06-11 | 가톨릭대학교 산학협력단 | 검정콩으로부터 추출한 안토시아닌을 포함하는 비세균성 전립선염의 예방 및 치료용 조성물 |
-
2014
- 2014-09-17 CN CN201410472993.2A patent/CN104173481B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN104173481A (zh) | 2014-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102526355A (zh) | 一种抗病毒治疗流感、感冒中药复方制剂 | |
CN104510853B (zh) | 一种治疗妇女痛经的中药有效部位组合物及其用途 | |
CN101347477B (zh) | 用于治疗类风湿性关节炎的药物组合物 | |
CN102552512B (zh) | 一种治疗乙肝的中药组合物 | |
CN102657736B (zh) | 一种治疗类风湿性关节炎的药物组合物及其制备方法 | |
CN101134092A (zh) | 一种治疗呼吸道疾病的中药复方制剂及其制备方法 | |
CN101485730A (zh) | 一种治疗小儿外感发热的药物组合物及其制备方法 | |
CN104524477A (zh) | 一种治疗结节性甲状腺肿的中药组合物 | |
CN111358906B (zh) | 一种适用于外感症的中药组合物 | |
CN104173481B (zh) | 一种抗前列腺炎症的中药组合物及其制备方法和应用 | |
CN101406548B (zh) | 一种治疗滑膜炎的中药制剂及制备工艺 | |
CN1985944A (zh) | 一种用于皮肤瘙痒、风疹等疾病的中药组合物 | |
CN103100010A (zh) | 一种治疗风湿性关节炎的药物 | |
CN108514627B (zh) | 一种治疗慢性荨麻疹的中药组合物 | |
CN102940747B (zh) | 治疗痛风的药物组合物 | |
CN102429979A (zh) | 一种治疗感冒的中药组合物及其制备方法 | |
CN107638453B (zh) | 一种妇炎婷颗粒及其制备方法 | |
CN101164591B (zh) | 一种祛风除湿药物组合物及其制备方法与用途 | |
CN101194959B (zh) | 一种治疗头痛的胶囊及其制备方法 | |
CN104510854A (zh) | 一种治疗妇女痛经的中药组合物及其用途 | |
CN105169009A (zh) | 一种中药组合物在制备治疗病毒性感冒药物中的应用 | |
CN1977904A (zh) | 一种用于盆腔炎、附件炎等妇科炎症的中药组合物 | |
CN101194965B (zh) | 一种治疗头痛的咀嚼片及其制备方法 | |
CN102429982A (zh) | 一种治疗感冒的中药颗粒剂及其制备方法 | |
CN102038834A (zh) | 用于预防和治疗癌症的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 212415 Jurong city of Jiangsu province Baohua Town Development Zone No. 10 Patentee after: JIANGSU TIANSHENG PHARMACEUTICAL Co.,Ltd. Address before: 212415 Zhenjiang city of Jiangsu province Jurong Baohua Development Zone No. 10 Patentee before: JIANGSU TIANSHENG PHARMACEUTICAL Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A traditional Chinese medicine composition for treating prostatitis and its preparation method and application Granted publication date: 20160921 Pledgee: Jiangsu Jurong Rural Commercial Bank Co.,Ltd. Baohua Branch Pledgor: JIANGSU TIANSHENG PHARMACEUTICAL Co.,Ltd. Registration number: Y2024980009757 |